Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer (ZAMBONEY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00811369
Recruitment Status : Completed
First Posted : December 19, 2008
Last Update Posted : November 18, 2013
Information provided by (Responsible Party):
Ontario Clinical Oncology Group (OCOG)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2012
  Study Completion Date : August 2013